Characteristics of coronary smooth muscle cells and adventitial fibroblasts

Circulation

Volumn 101, Issue 5, 2000, Pages 524-532

  Patel, Sachin ^a   Shi, Yi ^a   Niculescu, Rodica ^a   Chung, Eugene H ^a   Martin, Jack L ^b   Zalewski, Andrew ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b BRYN MAWR HOSPITAL   (United States)

Author keywords

Arteries; Cells; Muscle, smooth; Remodeling

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 4; EPIDERMAL GROWTH FACTOR; FIBRONECTIN; INTERLEUKIN 1ALPHA; LAMININ; MATRIGEL; PLATELET DERIVED GROWTH FACTOR BB; SOMATOMEDIN; VITRONECTIN;

ADVENTITIA; ANIMAL CELL; ARTICLE; CELL ADHESION; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CORONARY ARTERY; FIBROBLAST; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN METABOLISM; SMOOTH MUSCLE FIBER;

EID: 0034620478     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.5.524     Document Type: Article

References (51)

1. Austin GE, Ratliff NB, Hollman J, Tabei S, Philip DF. Intimai proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1985;6:369-375.
2. Epstein SE, Speir E, Zhou YF, Guetta E, Leon M, Finkel T. The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus. Lancet. 1996;348(suppl 1):13-17.
3. Ross R, Wight TN, Strandness E, Thiele B. Human atherosclerosis, I: cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol. 1984;114:79-93.
4. Gown AM, Tsukada T, Ross R. Human atherosclerosis, II: immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol. 1986;125:191-207.
5. Schwartz SM, deBlois D, O'Brien ERM. The intima: soil for atherosclerosis and restenosis. Circ Res. 1995;77:445-465.
6. Chamley-Campbell J, Campbell GR, Ross R. The smooth muscle cell in culture. Physiol Rev. 1979;59:1-61.
7. Seidel CL. Cellular heterogeneity of the vascular tunic media: implications for vessel wall repair. Arterioscler Thromb Vasc Biol. 1997;17: 1868-1871.
8. Zalewski A, Shi Y. Vascular myofibroblasts: lessons from coronary repair and remodeling. Arterioscler Thromb Vasc Biol. 1997;17:417-422.
9. Majesky M, Giachelli C, Reidy M, Schwartz S. Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated phenotype during repair of arterial injury. Circ Res. 1992;71:759-768.
10. Bochaton-Piallat ML, Ropraz P, Gabbiani F, Gabbiani G. Phenotypic heterogeneity of rat arterial smooth muscle clones: implications for the development of experimental intimai thickening. Arterioscler Thromb Vasc Biol. 1996;16:815-820.
11. Holifield B, Helgason T, Jemelka S, Taylor A, Navran S, Allen J, Seidel C. Differentiated vascular myocytes: are they involved in neointimal formation? J Clin Invest. 1996;97:814-825.
12. Frid MG, Dempsey EC, Durmowicz AG, Stenmark KR. Smooth muscle cell heterogeneity in pulmonary and systemic vessels: importance in vascular disease. Arterioscler Thromb Vasc Biol. 1997;17:1203-1209.
13. Shi Y, O'Brien JE, Mannion JD, Morrison RC, Chung W, Fard A, Zalewski A. Remodeling of autologous saphenous vein grafts: the role of perivascular myofibroblasts. Circulation. 1997;95:2684-2693.
14. Shi Y, O'Brien JE, Fard A, Mannion JD, Wang D, Zalewski A. Adventitiai myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation. 1996;94:1655-1664.
15. Scott NA, Cipolla GD, Ross CE, Dunn B, Martin FH, Simonet L, Wilcox JN. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation. 1996;93:2178-2187.
16. Shi Y, Pieniek M, Fard A, O'Brien J, Mannion JD, Zalewski A. Adventitial remodeling following coronary arterial injury. Circulation. 1996;93: 340-348.
17. Shi Y, O'Brien J, Fard A, Zalewski A. Transforming growth factor β1 expression and myofibroblast formation during arterial repair. Arterioscler Thromb Vasc Biol. 1996;16:1298-1305.
18. Shi Y, O'Brien Jr JE, Ala-Kokko L, Chung W, Mannion JD, Zalewski A. Origin of extracellular matrix synthesis during coronary repair. Circulation. 1997;95:997-1006.
19. Topouzis S, Majesky MW. Smooth muscle lineage diversity in the chick embryo: two types of aortic smooth muscle cell differ in growth and receptor-mediated transcriptional responses to transforming growth factor-β. Dev Biol. 1996;178:430-445.
20. Bogers AJJC, Gittenberger-de Groot AC, Poelmann RE, Peault BM, Huysmans HA. Development of the origin of the coronary arteries: a matter of ingrowth or outgrowth? Anat Embryol. 1989;180:437-441.
21. Mikawa T, Fischman DA. Retroviral analysis of cardiac morphogenesis: discontinuous formation of coronary vessels. Proc Natl Acad Sci U S A. 1992;89:9504-9508.
22. Mikawa T, Gourdie RG. Pericardial mesoderm generates a population of coronary smooth muscle cells migrating into the heart along with ingrowth of the epicardial organ. Dev Biol. 1996;174:221-232.
23. Peterkofsky B, Diegelmann R. Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins. Biochem. 1971;10:988-994.
24. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A. 1979;76:333-337.
25. Pittman RC, Carew TE, Glass CK, Green SR, Taylor CA, Attie AD. A radioiodinated, intracellularly trapped ligand for determining the sites of plasma protein degradation in vivo. Biochem J. 1983;212:791-800.
26. Goldstein JL, Basu SK, Brown MS. Receptor-mediated endocytosis of low-density lipoprotein in culture cells. Methods Enzymol. 1983;98: 241-260.
27. Zanellato AMC, Borrione AC, Giuriato L, Tonello M, Scannapieco G, Pauletto P, Sartore S. Myosin isoforms and cell heterogeneity in vascular smooth muscle, I: developing and adult bovine aorta. Dev Biol. 1990; 141:431-446.
28. Sartore S, Chiavegato A, Franch R, Faggin E, Pauletto P. Myosin gene expression and cell phenotypes in vascular smooth muscle during development, in experimental models, and in vascular disease. Arterioscler Thromb Vasc Biol. 1997;17:1210-1215.
29. Bochaton-Piallat M-L, Gabbiani G, Pepper MS. Plasminogen activator expression in rat smooth muscle cells depends on their phenotype and is modulated by cytokines. Circ Res. 1998;82:1086-1093.
30. McNamara CA, Sarembock IJ, Gimple LW, Fenton JW, Coughlin SR, Owens GK. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest. 1993;91:94-98.
31. Somasundaram C, Kallmeier RC, Babij P. Regulation of smooth muscle myosin heavy chain gene expression in cultured vascular smooth muscle cells by growth factors and contractile agonists. Basic Appl Mycol. 1995; 6:31-36.
32. Geary RL, Koyama N, Wang TW, Vergel S, Clowes AW. Failure of heparin to inhibit intimai hyperplasia in injured baboon arteries. Circulation. 1995;91:2972-2981.
33. Huckle WR, Drag MD, Acker WR, Powers M, McFall RC, Holder DJ, Fujita T, Stabilito II, Kim D, Ondeyka DL, Mantlo NB, Chang RSL, Reilly CF, Schwartz RS, Greenlee WJ, Johnson RG. Effects of subtype-selective and balanced angiotensin II receptor antagonists in a porcine coronary artery model of vascular restenosis. Circulation. 1996;93:1009-1019.
34. Stralin P, Karlsson K, Johansson BO, Marklund SL. The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol. 1995;15:2032-2036.
35. Bauriedel G, Windsetter U, De Maio SJ, Kandolf R, Höfling B. Migratory activity of human smooth muscle cells cultivated from coronary and peripheral primary and restenotic lesions removed by percutaneous atherectomy. Circulation. 1992;85:554-564.
36. Caplice NM, West MJ, Campbell GR, Campbell J. Inhibition of human vascular smooth muscle cell growth by heparin. Lancet. 1994;344:97-98.
37. Owens GK, Vernon SM, Madsen CS. Molecular regulation of smooth muscle differentiation. J Hypertens. 1996;14(suppl 5):S55-S64.
38. Thyberg J, Hultgardh-Nilsson A. Fibronectin and the basement membrane components laminin and collagen type IV influence the phenotypic properties of subcultured rat aortic smooth muscle cells differently. Cell Tissue Res. 1994;276:263-271.
39. Hein M, Fischer J, Kim D-K, Hein L, Pratt RE. Vascular smooth muscle cell phenotypic influences glycosaminoglycan composition and growth effects of extracellular matrix. J Vasc Res. 1996;33:433-441.
40. Bochaton-Piallat ML, Gabbiani F, Ropraz P, Gabbiani G. Age influences the replicative activity and the differentiation features of cultured rat aortic smooth muscle cell populations and clones. Arterioscler Thromb. 1993;13:1449-1455.
41. Björkerud B, Björkerud S. Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts. Arterioscler Thromb Vasc Biol. 1996;16:416-424.
42. Vlassara H, Fuh H, Makita Z, Krungkrai S, Cerami A, Bucala R. Exogenous advanced glycosylation endproducts induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc Natl Acad Sci U S A. 1992;89:12043-12047.
43. Chamley JH, Campbell GR, McConnell JD. Comparison of vascular smooth muscle cells from adult human, monkey and rabbit in primary culture and subculture. Cell Tissue Res. 1977;177:503-522.
44. Darby I, Skalli O, Gabbiani G. α-Smooth muscle actin is transiently expressed in by myofibroblasts during experimental wound healing. Lab Invest. 1990;63:21-29.
45. Grinnell F. Fibroblasts, myofibroblasts, and wound contraction. J Cell Biol. 1994;124:401-404.
46. Shi Y, Patel S, Niculescu R, Chung W, Desrochers P, Zalewski A. Role of matrix metalloproteinases and their tissue inhibitors in the regulation of coronary cell migration. Arterioscler Thromb Vasc Biol. 1999;19: 1150-1155.
47. Nobuyoshi M, Kimura T, Ohishi H, Horiuchi H, Nosaka H, Hamasaki N, Yokoi H, Kim K. Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients. J Am Coll Cardiol. 1991;17:433-439.
48. Wal AC, Becker AE, Das PK. Medial thinning and atherosclerosis: evidence for involvement of a local inflammatory effect. Atherosclerosis. 1993;103:55-64.
49. Isner JM, Donaldson RF, Fortin AH, Tischler A, Clarke RH. Attenuation of the media of coronary arteries in advanced atherosclerosis. Am J Cardiol. 1986;58:937-939.
50. Edelman ER, Adams DH, Karnovsky MJ. Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury. Proc Natl Acad Sci U S A. 1990;87:3773-3777.
51. Christen T, Bochaton-Piallat ML, Neuville P, Rensen S, Redard M, van Eys G, Gabbiani G. Cultured porcine coronary artery smooth muscle cells: a new model with advanced differentiation. Circ Res. 1999;85: 99-107.